Entity Details
| Primary name |
NAKD2_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | Q4G0N4 |
| EntryName | NAKD2_HUMAN |
| FullName | NAD kinase 2, mitochondrial |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 442 |
| SequenceStatus | complete |
| DateCreated | 2007-07-24 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Mitochondrion |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR002504 | NAD kinase | Family | Family |
| IPR012355 | NAD kinase 2, mitochondrial | Family | Family |
| IPR016064 | NAD kinase/diacylglycerol kinase-like domain superfamily | Family | Homologous superfamily |
| IPR017437 | ATP-NAD kinase, PpnK-type, C-terminal | Family | Homologous superfamily |
| IPR017438 | Inorganic polyphosphate/ATP-NAD kinase, N-terminal | Family | Homologous superfamily |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 616034 | OMIM | 2,4-dienoyl-CoA reductase deficiency (DECRD) | A rare, autosomal recessive, inborn error of polyunsaturated fatty acids and lysine metabolism, resulting in mitochondrial dysfunction. Affected individuals have a severe encephalopathy with neurologic and metabolic abnormalities beginning in early infancy. Laboratory studies show increased C10:2 carnitine levels and hyperlysinemia. The disease is caused by variants affecting the gene represented in this entry. |
Interactions
0 interactions
| Interactor | Partner | Sources | Publications | Link |